secwatch.observer — SEC 8-K summary
======================================

Issuer:     OnKure Therapeutics, Inc. (OKUR)
CIK:        0001637715
Form:       8-K
Filed at:   2023-05-05T23:59:59+00:00
Accession:  0001193125-23-137165
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Reneo Pharmaceuticals prices public offering of 6.875M shares at $8.00, expects net proceeds ~$58.2M
--------------------------------------------------------------------------------

- Public offering of 6.875M shares at $8.00/share; underwriters exercised overallotment for 1.031M additional shares in full.
- Net proceeds expected approx. $58.2M after underwriting discounts and expenses.
- Concurrent $5.0M private placement to Abingworth Bioventures at same $8.00/share, closing conditioned on public offering.
- Offering expected to close May 8, 2023; shares sold under effective S-3 shelf registration.
- Jefferies, BofA Securities, and Piper Sandler act as joint book-running managers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1637715/000119312523137165/0001193125-23-137165-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1637715/000119312523137165/d362041d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-137165

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer